HDAC9 and hepatocellular carcinoma: Unlike prototypical HDAC inhibitors,however, the toxicity of these glycosylated HDACi is restricted tothe HCC cells as STR-V-53 and STR-I-195 inducedapoptosis in Hep-G2 cells and not in VERO cells.